Sustainable Cold Chain Through Dry-Ice-Free Ultra-Low-Temperature Transport

「The company and Toho Pharmaceutical Co., Ltd. established a system for supplying quality-control materials for biochemical testing that requires advanced refrigerated transport, achieving dry-ice-free operations by reducing the number of shipments, reusing transport materials and eliminating dry ice throughout the transport process. Combining consolidated shipments with deliveries of regular products by a pharmaceutical wholesaler, this is the first initiative in Japan's diagnostics industry to achieve dry-ice-free transport over long distances and extended periods, and is expected to make a significant contribution as an environmentally friendly, sustainable cold chain.」

「As a new logistics initiative, the company and Yamato Transport Co., Ltd. began consolidated shipments of reagents for genetic testing at ultra-low temperatures below minus 70°C without using dry ice. This is a groundbreaking model that combines environmental considerations with low cost by eliminating dry ice, previously considered indispensable for long-distance transport of pharmaceuticals and other products requiring strict quality and temperature control. Going forward, the company will use this model to expand the products and delivery areas covered, achieve a sustainable pharmaceutical cold chain, and provide high-quality, stable supplies to healthcare facilities.」